Management of detrusor external sphincter dyssynergia in neurogenic bladder

European Journal of Physical and Rehabilitation Medicine

Volumn 47, Issue 4, 2011, Pages 639-650

  Mahfouz, W ^a   Corcos, J ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Electromyography; Neurogenic; Spinal cord injuries; Urinary bladder

Indexed keywords

ANTIPARKINSON AGENT; BOTULINUM TOXIN; MUSCARINIC RECEPTOR BLOCKING AGENT;

ATAXIA; BALLOON DILATATION; DRUG EFFECT; HUMAN; MALE; NEUROGENIC BLADDER; PATHOLOGICAL REFLEX; PATHOPHYSIOLOGY; REVIEW; SPINAL CORD INJURY; STENT; URETHRA;

ANTI-DYSKINESIA AGENTS; ATAXIA; BALLOON DILATION; BOTULINUM TOXINS; HUMANS; MALE; MUSCARINIC ANTAGONISTS; REFLEX, ABNORMAL; SPINAL CORD INJURIES; STENTS; URETHRA; URINARY BLADDER, NEUROGENIC;

EID: 84859300134     PISSN: 19739087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Ahmed HU, Shergill IS, Arya M, Shah PJ. Management ofdetrusor-external sphincter dyssynergia. Nat Clin Pract Urol 2006;3:368-80.
2. DeVivo MJ, Rutt RD, Black KJ, Go BK, Stover SL. Trends inspinal cord injury demographics and treatment outcomes between 1973 and 1986. Arch Phys Med Rehabil 1992;73:424-30.
3. Frankel HL, CoIl JR, Charlifue SW, Whiteneck GG, Gardner BP, Jamous MA et al. et al. Long-term survival in spinal cord injury: a fifty year investigation. Spinal Cord 1998;36:266-74.
4. Blaivas JG, Sinha HP, Zayed AA, Labib KB. Detrusor-external sphincter dyssynergia. J Urol 1981;125:542-4. (Pubitemid 11116657)
5. Wein A, Kavoussi L, Novick A, Partin A, Peters C, eds. CampbellWalsh Urology. Ninth edition. Philadelphia: Saunders; 2007.
6. Hackler RH. A 25-year prospective mortality study in the spinal cord injured patient: comparison with the long-term living paraplegic. J Urol 1977;117:486-8. (Pubitemid 8093952)
7. Blaivas JG. The neurophysiology ofmicturition: a clinical study of 550 patients. J Urol 1982;127:958-63. (Pubitemid 12124259)
8. Chancellor M, Rivas D, editors. Current management of detrusor-sphincter dyssynergia. St. Louis: CV Mosby; 1995- McGuire E, ed. Advances in Urology.
9. Wein A, Rovner E. Adult voiding dysfunction secondary to neurologic disease or injury. AUA Update Series 1999;18:42-7.
10. Hinman F, Jr. Nonneurogenic neurogenic bladder (the Hinman syndrome)-15 years later. J Urol 1986;136:769-77.
11. Schurch B, Schmid DM, Karsenty G, Reitz A. Can neurologic examination predict type of detrusor sphincter-dyssynergia in patients with spinal cord injury? Urology 2005;65:243-6. (Pubitemid 40248005)
12. Weld KJ, Graney MJ, Dmochowski RR. Clinical significance ofdetrusor sphincter dyssynergia type in patients with post-traumatic spinal cord injury. Urology 2000;56:565-8.
13. Wein A, Barrett DM. Etiologic possibilities for increased pelvic floor electromyography activity during cystometry. J Urol 1982;127:949-52. (Pubitemid 12124257)
14. Rudy D. Detmsor-external sphincter dyssynergia. Probl Urol 1993;7:68-93.
15. Kim YH, Kattan MW, Boone TB. Bladder leak point pressure: the measure for sphincterotomy success in spinal cord injured patients with external detmsor-sphincter dyssynergia. J Urol 1998;159:493-6.
16. Kelly C, Nitti V, editors. Evaluation of neurogenic bladder dysfunction: basic urodynamics. Second edition. London: Informa; 2008. Coreos J, Schick E, editors. Textbook of the Neurogenic bladder.
17. Gades NM, Jacobson DJ, Girman CJ, Roberts RO, Lieber MM, Jacobsen SJ. Prevalence ofconditions potentially associated with lower urinary tract symptoms in men. BJU Int 2005;95:549-53. (Pubitemid 40311471)
18. McGuire EJ, Woodside JR, Borden TA, Weiss RM. Prognostic value ofurodynamic testing in myelodysplastic patients. J Urol 1981;126:205-9. (Pubitemid 11012925)
19. Wein A, editor. Voiding function and dysfunction; urinary incontinence Philadelphia: Saunders; 2007. Hanno P, Malkowicz B, Wein A, editors. Penn Clinical Manual of Urology.
20. Chancellor MB, Erhard MJ, Rivas DA. Clinical effect ofalpha-1 antagonism by terazosin on external and internal urinary sphincter function. J Am Paraplegia Soc 1993;16:207-14.
21. Bennett JK, Foote J, El-Leithy TR, Saleem MD, Green B, Archer CL et al. Terazosin for vesicosphincter dyssynergia in spinal cord-injured male patients. Mol Urol. Winter 2000;4:415-20.
22. Kim YH, Bird ET, Priebe M, Boone TB. The role ofoxybutynin in spinal cord injured patients with indwelling catheters. J Urol 1997;158:2083-6. (Pubitemid 27481332)
23. Scarpero HM, Dmochowski RR. Muscarinic receptors: what weknow. Curr Urol Rep 2003;4:421-8.
24. Yamanishi T, Chapple CR, Chess-Williams R. Which muscarinic receptor isimportant in the bladder? World J Urol 2001;19:299-306. (Pubitemid 33777074)
25. Lindehall B, Abrahamsson K, Hjalmas K, Jodal U, Olsson I, Sillen U. Complications ofclean intermittent catheterizatipn in boys and young males with neurogenic bladder dysfunction. J Urol 2004;172(4 Pt 2):1686-8. (Pubitemid 39245017)
26. Wyndaele JJ. Complications ofintermittent catheterization: their prevention and treatment. Spinal Cord 2002;40:536-41. (Pubitemid 35193278)
27. Wyndaele JJ. Intermittent catheterization: which isthe optimal technique? Spinal Cord 2002;40:432-7. (Pubitemid 35001730)
28. Groah SL, Weitzenkamp DA, Lammertse DP, Whiteneck GG, Lezotte DC, Hamman RF. Excess risk ofbladder cancer in spinal cord injury: evidence for an association between indwelling catheter use and bladder cancer. Arch Phys Med Rehabil 2002;83:346-51. (Pubitemid 34204816)
29. Chancellor MB, Karasick S, Strup S, Abdul CK, Hirsch IH, Staas WE. Transurethral balloon dilation ofthe external urinary sphincter: effectiveness in spinal cord-injured men with detrusor-external urethral sphincter dyssynergia. Radiology 1993;187:557-60. (Pubitemid 23127872)
30. Chancellor MB, Rivas DA, Abdill CK, Karasick S, Ehrlich SM, Staas WE. Prospective comparison ofexternal sphincter balloon dilatation and prosthesis placement with external sphincterotomy in spinal cord injured men. Arch Phys Med Rehabil 1994;75:297-305. (Pubitemid 24099563)
31. Dykstra DD, Sidi AA, Scott AB, Pagel JM, Goldish GD. Effects of botulinum Atoxin on detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol 1988;139:919-22.
32. Apostolidis A, Dasgupta P, Denys P, Elneil S, Fowler CJ, Giannantoni A et al. Recommendations onthe use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report. Eur Urol 2009;55:100-19.
33. Schurch B, Hauri D, Rodic B, Curt A, Meyer M, Rossier AB. Botulinum-A toxin as atreatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients. J Urol 1996;155:1023-9. (Pubitemid 26052703)
34. Olsen AL, Benson JT, McClellan E. Urethral sphincter needle electromyography in women: comparison of periurethral and transvaginal approaches. Neurourol Urodyn 1998;17:531-5. (Pubitemid 28462646)
35. Schurch B, Hodler J, Rodic B. Botulinum Atoxin as a treatment of detrusor-sphincter dyssynergia in patients with spinal cord injury: MRI controlled transperineal injections. J Neurol Neurosurg Psychiatry 1997;63:474-6.
36. Smith CP, Nishiguchi J, O'Leary M, Yoshimura N, Chancellor MB. Single-institution experience in110 patients with botulinum toxin A injection into bladder or urethra. Urology 2005,65:37-41. (Pubitemid 40169601)
37. Karsenty G, Baazeem A, Elzayat E, Coreos J. Injection ofbotulinum toxin type A in the urethral sphincter to treat lower urinary tract dysfunction: a review of indications, techniques and results. Can J Urol 2006;13:3027-33.
38. Nambirajan T, Woolsey S, Mahendra V, Stone AR, Walsh IK. Urethral stents for detrusor sphincter dyssynergia. BJU Int 2005;95:350-3. (Pubitemid 40283122)
39. Milroy EJ, Chapple CR, Cooper JE, Eldin A, Wallsten H, Seddon AM et al. A new treatment for urethral strictures. Lancet 1988;1:1424-7.
40. Shaw PJ, Milroy EJ, Timoney AG, el Din A, Mitchell N. Permanent external striated sphincter stents in patients with spinal injuries. Br J Urol 1990;66:297-302. (Pubitemid 20298506)
41. Chancellor MB, Gajewski J, Ackman CF, Appell RA, Bennett J, Binard J et al. Long-term followup ofthe North American multicenter UroLume trial for the treatment of external detrusorsphincter dyssynergia. J Urol 1999;161:1545-50. (Pubitemid 29420816)
42. Sauerwein D, Gross AJ, Kutzenberger J, Ringert RH. Wall-Stents inpatients with detrusor-sphincter dyssynergia. J Urol 1995;154(2 Pt 1):495-7.
43. Hamid R, Arya M, Patel HR, Shah PJ. The mesh wallstent inthe treatment of detrusor external sphincter dyssynergia in men with spinal cord injury: a 12-year follow-up. BJU Int 2003;91: 51-3.
44. Gajewski JB, Chancellor MB, Ackman CF, Appell RA, Bennett J, Binard J et al. Removal ofUroLume endoprosthesis: experience of the North American Study Group for detrusor-sphincter dyssynergia application. J Urol 2000;163:773-6. (Pubitemid 30091613)
45. Guazzoni G, Montorsi F, Coulange C, Milroy E, Pansadoro V, Rubben H. et al. A modified prostatic UroLume Wallstent for healthy patients with symptomatic benign prostatic hyperplasia: a European Multicenter Study. Urology 1994;44:364-70. (Pubitemid 24273819)
46. Soni BM, Vaidyanatham S, Krishnan KR. Use of Memokath, asecond generation urethral stent for relief of urinary retention in male spinal cord injured patients. Paraplegia 1994;32: 480-8. (Pubitemid 24213386)
47. Reynard JM, Vass J, Sullivan ME, Mamas M. Sphincterotomy and the treatment of detrusor-sphincter dyssynergia: current status, future prospects. Spinal Cord 2003;41:1-11. (Pubitemid 36132536)
48. Ross JC, Gibbon NO, Damanski M. Division ofthe external sphincter in the treatment of the neurogenic bladder. BrJ Surg 1967;54:627-8.